Traditional photothermal therapy requires high‐intensity laser excitation for cancer
treatments due to the low photothermal conversion efficiency (PCE) of photothermal agents …

Improving photothermal conversion efficiency (PCE) is critical to facilitate therapeutic
performance during photothermal therapy (PTT). However, current strategies of prompting …

Photothermal therapy (PTT) represents a promising noninvasive tumor therapeutic modality,
but the current strategies for enhancing photothermal effect have been mainly based on …

Optimal nanosized drug delivery systems (NDDS) require long blood circulation and
controlled drug release at target lesions for efficient anticancer therapy. Red blood cell …

Photothermal therapy (PTT) has attracted extensive research attention as a noninvasive and
selective treatment strategy for numerous cancers. PTT functions via photothermal effects …

Abstract Near-infrared (NIR) laser-induced photothermal therapy (PTT) uses a photothermal
agent to convert optical energy into thermal energy and has great potential as an effective …

It remains highly challenging to identify small molecule‐based photothermal agents with a
high photothermal conversion efficiency (PTCE). Herein, we adopt a double bond‐based …

Photothermal therapy (PTT) as a kind of noninvasive tumor treatment has attracted
increasing research interest. However, the efficiency of existing PTT agents in the near …

The development of agents for noninvasive photothermal/photodynamic therapies
(PTT/PDT) against cancer remains challenging because most PTT agents cause side effects …

Organic photothermal nanoagents are promising candidates for treating primary tumors and
inhibiting metastasis. However, they often exhibit poor photostability, low absorptivity, or …